dorbymiao
2021-11-06
$Moderna, Inc.(MRNA)$
stock is crashing down partly because of this?
Pfizer vs. Merck: A Look at the Two New Covid Pill Treatments
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
1
1
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":842181295,"tweetId":"842181295","gmtCreate":1636155841382,"gmtModify":1636155841466,"author":{"id":4093220244813210,"idStr":"4093220244813210","authorId":4093220244813210,"authorIdStr":"4093220244813210","name":"dorbymiao","avatar":"https://static.tigerbbs.com/36a7b09dc1d7fdc5a2065eaf815a696e","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":4,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p><a href=\"https://laohu8.com/S/MRNA\">$Moderna, Inc.(MRNA)$</a>stock is crashing down partly because of this?</p></body></html>","htmlText":"<html><head></head><body><p><a href=\"https://laohu8.com/S/MRNA\">$Moderna, Inc.(MRNA)$</a>stock is crashing down partly because of this?</p></body></html>","text":"$Moderna, Inc.(MRNA)$stock is crashing down partly because of this?","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/842181295","repostId":1188368870,"repostType":4,"repost":{"id":"1188368870","pubTimestamp":1636122141,"share":"https://www.laohu8.com/m/news/1188368870?lang=&edition=full","pubTime":"2021-11-05 22:22","market":"us","language":"en","title":"Pfizer vs. Merck: A Look at the Two New Covid Pill Treatments","url":"https://stock-news.laohu8.com/highlight/detail?id=1188368870","media":"Bloomberg","summary":"Pfizer Inc. released data on its experimental Covid pill Friday that suggest a potential challenge t","content":"<p>Pfizer Inc. released data on its experimental Covid pill Friday that suggest a potential challenge to molnupiravir, the drug from Merck & Co. and Ridgeback Biotherapeutics LP that’s already been cleared for use in the U.K.</p>\n<p>While the Pfizer pill showed an 89% reduction in hospitalization or death in high-risk Covid-19-infected individuals, and Merck’s showed a 50% reduction, “we can’t yet compare the two until the risk profile of the patients is clearer,” according to Bloomberg Intelligence analyst Sam Fazeli.</p>\n<p>Here are a few facts that we can put side-by-side until the data are analyzed further:</p>\n<p><img src=\"https://static.tigerbbs.com/12b6a26c0eef9971bb0ec9371bb3a756\" tg-width=\"969\" tg-height=\"650\" width=\"100%\" height=\"auto\"></p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer vs. Merck: A Look at the Two New Covid Pill Treatments</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer vs. Merck: A Look at the Two New Covid Pill Treatments\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-05 22:22 GMT+8 <a href=https://www.bloomberg.com/news/articles/2021-11-05/pfizer-vs-merck-a-look-at-the-two-new-covid-treatments><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Pfizer Inc. released data on its experimental Covid pill Friday that suggest a potential challenge to molnupiravir, the drug from Merck & Co. and Ridgeback Biotherapeutics LP that’s already been ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-11-05/pfizer-vs-merck-a-look-at-the-two-new-covid-treatments\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","MRK":"默沙东"},"source_url":"https://www.bloomberg.com/news/articles/2021-11-05/pfizer-vs-merck-a-look-at-the-two-new-covid-treatments","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1188368870","content_text":"Pfizer Inc. released data on its experimental Covid pill Friday that suggest a potential challenge to molnupiravir, the drug from Merck & Co. and Ridgeback Biotherapeutics LP that’s already been cleared for use in the U.K.\nWhile the Pfizer pill showed an 89% reduction in hospitalization or death in high-risk Covid-19-infected individuals, and Merck’s showed a 50% reduction, “we can’t yet compare the two until the risk profile of the patients is clearer,” according to Bloomberg Intelligence analyst Sam Fazeli.\nHere are a few facts that we can put side-by-side until the data are analyzed further:","news_type":1},"isVote":1,"tweetType":1,"viewCount":482,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["MRNA"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":59,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/842181295"}
精彩评论